SEC Form 4 · accession 0001209191-16-119705
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rajinder Singh
Officer — SVP, Research
Period of report
May 9, 2016
Accepted (ET)
May 12, 2016 · 7:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $2.10 | May 9, 2016 | A | 180,000 | A | — | May 9, 2026 | Common Stock | 180,000 | 180,000 | D |
Explanation of responses
- F1The option was granted on May 9, 2016. 25% of the total number of shares of common stock subject to the option will vest on May 2, 2017, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
- F2Not applicable.